GlassScriptPhysician profile
Stephen Hugh Bailey
NPI 1033185277
$32,782.19
in general payments reported to CMS, 2019-2025
22 companies · $3,178 in 2025
The $3,178 reported for 2025 was more than what 75% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,316 · 2020: $4,755 · 2021: $7,358 · 2022: $4,521 · 2023: $924 · 2024: $3,729 · 2025: $3,178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,074 · Travel and Lodging: $1,757.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,073.98 |
| Travel and Lodging | $1,757.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $13,515.80 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $7,949.74 | 2019-2025 | Epic, Navitor, Mitraclip |
| Covidien LP | $3,850.00 | 2020 | |
| Medtronic, INC. | $3,250.11 | 2021-2025 | Corevalve Evolut R |
| Medtronic Vascular, INC. | $1,169.78 | 2019-2020 | |
| Abiomed | $714.51 | 2019-2025 | Impella |
| Boston Scientific Corporation | $397.75 | 2019-2020 | |
| Atricure, INC. | $352.56 | 2019-2024 | |
| Cerus Corporation | $291.74 | 2022-2024 | Intercept Blood System For Platelets |
| Silk Road Medical, INC. | $228.47 | 2019-2022 | |
| Stryker Corporation | $167.76 | 2025 | Venacore Thrombectomy Catheter |
| Irhythm Technologies, INC. | $167.00 | 2022 | |
| Centerline Biomedical INC. | $130.82 | 2020 | |
| Medtronic USA, INC. | $118.11 | 2020 | |
| Olympus America INC. | $109.05 | 2024 | Hanarostent Esophagus Tts(Ccc) |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $90.34 | 2021 | |
| Livanova USA, INC. | $88.24 | 2019-2021 | |
| Ethicon US, LLC | $85.18 | 2021-2022 | |
| Novo Nordisk INC | $39.48 | 2019 | |
| Janssen Pharmaceuticals, INC | $37.97 | 2021 | |
| Smith+Nephew, INC. | $20.40 | 2025 | Pico |
| Altathera Pharmaceuticals LLC | $7.38 | 2024 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.